ALP AI

ALP AI is pioneering immunogenicity intelligence for biologics. Our platform combines human tonsil organoids with generative AI to predict and prevent immune responses (ADAs) before clinical trials. We help drug developers de-risk pipelines and launch safer, more effective antibody therapies.